Table 4.

Multiple linear regression analyses of the main scales in the BREAST-Q BCT module and clinicopathologic risk factors

	T3: satisfaction with breasts (n = 179)		T3: psychosocial well-being (n = 181)		T3: physical well-being (n = 179)		T3: sexual well-being (n = 155)
	p Value	B	p Value	B	p Value	B	p Value	B
Model-adjusted R2		0.103		0.300		0.200		0.375
T1: satisfaction with breasts	0.212		0.631		0.007a	–0.180	0.578
T1: psychosocial well-being	0.028a	0.283	0.000a	0.601	0.003a	0.224	0.978
T1: physical well-being	0.478		0.355		0.001a	0.214	0.008a	0.268
T1: sexual well-being	0.295		0.183		0.582		0.000a	0.580
Age at surgery (years)	0.867		0.341		0.155		0.367
BMI at surgery	0.048a	–0.772	0.869		0.997		0.370
Type of surgery (reference category, see Table 1)	0.816		0.668		0.502		0.620
Type of incision (reference category, see Table 1)	0.092a	–3.968	0.803		0.510		0.454
Type of axillary surgery (reference category, see Table 1)	0.619		0.201		0.992		0.004a	–9.414
Re-excision	0.789		0.846		0.912		0.452
Pathologic tumor size (mm)	0.175		0.559		0.885		0.372
Resected tissue weight (g)	0.649		0.551		0.342		0.391
pT	0.869		0.003a	–0.315	0.050a	0.139	0.387
pN	0.374		0.763		0.499		0.017a	1.374
Neoadjuvant CHT	0.955		0.886		0.802		0.895
Adjuvant CHT	0.631		0.014a	10.039	0.112		0.090a	6.953
Endocrine therapy	0.876		0.762		0.167		0.824
Seroma	0.761		0.120		0.074a	5.821	0.072a	9.466
Impaired wound healing	0.373		0.752		0.294		0.208

BCT breast-conserving therapy, B regression coefficient, Model-adjusted R2, adjusted coefficient of determination, BMI body mass index, CHT chemotherapy

^ap < 0.10